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Mercury is a toxic metal that has been used 
by humans for centuries as a constituent of 
medicines, scientific instruments, fungicides, 
and other items, in addition to being used in 
many industrial processes (Goldwater 1972). 
It is most recognizable in its elemental (metal-
lic) state (Hg0) as a silvery liquid at room 
tempera  ture. However, in its most common 
oxidation state (Hg2+), it can form a wide 
range of compounds.
In the United States, people are exposed 
to mercury most frequently by eating fish in 
which the organic compound methyl  mercury 
(CH3Hg+) has accumulated. However, expo-
sure to inorganic forms of mercury can also 
occur such as during inhalation of vapors from 
accidental spills, in workplace activities (e.g., 
the manufacture of chlor  alkali compounds 
and mercury-containing devices), from dental 
amalgams, or from ritualistic or cultural prac-
tices that involve elemental mercury [Agency 
for Toxicological Substances and Disease 
Registry (ATSDR) 1999]. Approximately 
80% of elemental mercury vapor is absorbed 
by the human body through inhalation, in 
contrast with ingestion or dermal exposure 
to elemental mercury, which rarely results in 
toxicity [International Program on Chemical 
Safety (IPCS) 1991]. Once absorbed, the 
dissolved vapor readily crosses the placenta 
and the blood–brain barrier, where it can 
be harmful to the developing nervous sys-
tem or interfere with neurological function. 
The kidney is also a principal site of toxicity 
(Clarkson et al. 2003).
In New York City (NYC), the relative 
importance of exposure to elemental mer-
cury has been debated [Newby et al. 2006; 
U.S. Environmental Protection Agency 
(EPA) 2002; Wendroff 1997]. Certain 
Afro-Caribbean and Latin American tradi-
tions, including Santeria, Espiritismo, Palo 
Mayombe, and Voodoo have been known 
to practice rituals that involve sprinkling 
mercury around a home, wearing it in an 
ampule or amulet, burning it in a candle, or 
mixing it with perfume (Riley et al. 2001). 
These practices are believed to ward off evil, 
provide protection, and bring good luck 
(U.S. EPA 2002). They can also result in 
mercury volatiliza  tion and human exposure 
via inhalation, especially when large amounts, 
high temperatures, and frequent handling are 
involved (Riley et al. 2001).
Ingestion of traditional medicine products 
and the topical application of skin-lightening 
creams and other skin care products that con-
tain mercury are also known sources of expo-
sure to inorganic mercury. Small amounts of 
ingested inorganic mercury compounds may 
be absorbed by the gastrointestinal tract (up 
to 10%, although the amount may be greater 
in young children), but only a fraction of 
this amount is likely to cross the blood–brain 
barrier (IPCS 1991). The kidney is the pri-
mary target of toxicity for ingested inorganic 
mercury compounds (IPCS 1976). Topically 
applied mercury compounds are more readily 
absorbed and are also most likely to accu-
mulate in and cause damage to the kidneys, 
although high levels of exposure may also 
affect the nervous system (IPCS 1991; Kern 
et al. 1991). Topical exposures have also been 
known to cause acrodynia in children. This 
condition manifests with cardiovascular, der-
mal, and neurological symptoms such as irri-
tability, photophobia, pink discoloration of 
the hands and feet, and polyneuritis (Boyd 
et al. 2000).
In 2004, NYC conducted the first 
local health and nutrition examination sur-
vey (HANES) in the United States, using a 
representative sample of adults. The survey 
was modeled after the National Health and 
Nutrition Examination Survey (NHANES)
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ba c K g R O u n d: Mercury is a toxic metal that has been used for centuries as a constituent of 
  medicines and other items. 
Ob j e c t i v e: We assessed exposure to inorganic mercury in the adult population of New York City 
(NYC).
Me t h O d s : We measured mercury concentrations in spot urine specimens from a representative 
sample of 1,840 adult New Yorkers in the 2004 NYC Health and Nutrition Examination Survey. 
Cases with urine concentrations ≥ 20 μg/L were followed up with a telephone or in-person inter-
view that asked about potential sources of exposure, including ritualistic/cultural practices, skin care 
products, mercury spills, herbal medicine products, and fish.
Re s u l t s: Geometric mean urine mercury concentration in NYC was higher for Caribbean-born 
blacks [1.39 μg/L; 95% confidence interval (CI), 1.14–1.70] and Dominicans (1.04 μg/L; 95% CI, 
0.82–1.33) than for non-Hispanic whites (0.67 μg/L; 95% CI, 0.60–0.75) or other racial/ethnic   
groups. It was also higher among those who reported at least 20 fish meals in the past 30 days 
(1.02 μg/L; 95% CI, 0.83–1.25) than among those who reported no fish meals (0.50 μg/L; 95% CI, 
0.41–0.61). We observed the highest 95th percentile of exposure (21.18 μg/L; 95% CI, 7.25–51.29) 
among Dominican women. Mercury-containing skin-lightening creams were a source of exposure 
among those most highly exposed, and we subsequently identified 12 imported products containing 
illegal levels of mercury in NYC stores.
cO n c l u s i O n: Population-based biomonitoring identified a previously unrecognized source of 
exposure to inorganic mercury among NYC residents. In response, the NYC Health Department 
embargoed products and notified store owners and the public that skin-lightening creams and other 
skin care products that contain mercury are dangerous and illegal. Although exposure to inorganic 
mercury is not a widespread problem in NYC, users of these products may be at risk of health 
effects from exposure.
Key w O R d s : biomonitoring, inorganic mercury poisoning, mercury, National Health and Nutrition 
Examination Survey, New York City, NYC HANES, skin care, skin-lightening creams, urine. 
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[Centers for Disease Control and Prevention 
(CDC) 2010] and included a biomonitoring 
component that measured total mercury con-
centration in blood and in urine. The latter is 
typically used to assess exposure to inorganic 
mercury, because virtually all mercury in urine 
is inorganic (ATSDR 1999; Carrier et al. 
2001). Local biomonitoring was conducted 
under the premise that the relative impor-
tance of population exposures and sources can 
vary according to cultural, behavioral, and 
demographic characteristics of an area. 
Using the results from the NYC HANES, 
we have described the distribution and deter-
minants of exposure to inorganic mercury in 
NYC adults, as well as the NYC Department 
of Health and Mental Hygiene (DOHMH) 
response to the findings.
Materials and Methods
Sample selection. The NYC HANES was a 
population-based, cross-sectional survey that 
represented the civilian, noninstitutionalized 
adult (≥ 20 years of age) population residing in 
the five boroughs of NYC (Bronx, Brooklyn, 
Manhattan, Queens, and Staten Island). The 
survey was conducted between June and 
December 2004. Participants were recruited 
into the study using a three-stage cluster- 
sampling design. The stages of sample selec-
tion were a) selection of census blocks, or 
groups of blocks; b) enumeration and random 
selection of households within selected areas; 
and c) random selection of study participants 
within households. The target sample size was 
2,000.
Data collection. Individuals who were 
selected to participate in the study were 
invited to any of four clinic sites in the bor-
oughs of Manhattan, Brooklyn, the Bronx, 
or Queens to be interviewed and examined 
(including blood and urine collection). 
Using a face-to-face, computer-assisted per-
sonal interview, study participants were 
asked their age, sex, race/ethnicity [white; 
black or African American; Asian/Hawaiian/
Pacific Islander (referred to here as Asian); 
Native American/Alaskan Native or other; 
and whether they considered themselves to be 
Hispanic or Latino], education, income, place 
of birth, and length of time in the United 
States. Participants who identified themselves 
as Hispanic were asked about their country 
of origin. All participants were asked about 
the number of fish or shellfish meals they had 
eaten in the past 30 days. We translated the 
survey instrument into Spanish; interviews in 
other languages were conducted by an NYC 
DOHMH staff member, by a participant’s 
family member, or by a telephone translation 
service (Language Line, Monterey, CA).
Spot urine specimens were collected using 
supplies certified for trace metal measure-
ments by the Wadsworth Center’s Laboratory 
of Inorganic and Nuclear Chemistry (clini-
cal trace elements section) at the New York 
State Department of Health (NYS DOH) 
in Albany, NY. Aliquots of urine preserved 
with sulfamic acid and Triton-X 100 (Sigma-
Aldrich Corp., St. Louis, MO) to prevent mer-
cury loss were shipped on dry ice in Nalgene 
cryovials (Thermo Fisher Scientific, Rochester, 
NY) to the Wadsworth Center laboratory at 
the New York State Department of Health. 
Specimens were stored at –80 °C (Thermo 
Scientific, Asheville, NC) until they could 
be analyzed. The Wadsworth Center is cer-
tified under the federal Clinical Laboratory 
Improvements Amendments of 1988 (CLIA; 
Centers for Medicaid and Medicare Services 
2010) and holds a clinical laboratory permit 
for measuring trace elements from NYS DOH.
The NYC HANES protocol was approved 
by the NYC DOHMH and the NYS DOH 
institutional review boards. Study participants 
provided written, informed consent, and those 
who provided interview and laboratory data 
were remunerated $100. Information on data 
collection and protocols, as well as a detailed 
description of the study design, have been 
published elsewhere (Thorpe et al. 2006).
Laboratory methods. Total mercury con-
centration in urine was determined using a 
method optimized for a PerkinElmer Sciex 
(Shelton, CT) ELAN DRC II inductively 
coupled plasma mass spectrometer (ICP-MS) 
(Parsons et al. 2005). The Wadsworth 
Center laboratory calibrated the instrument 
using inorganic mercury standards traceable 
to the National Institute of Standards and 
Technology (NIST; Gaithersburg, MD). Five 
different concentrations of internal quality 
control (IQC) materials that covered the range 
of exposure expected in the U.S. population 
were analyzed at the beginning and end of 
each batch of specimens and throughout each 
analytical run. The coefficient of variation 
(a measure of reproducibility) varied from 
4.5% at 3.8 ug/L to 6.1% at 38 ug/L. NIST 
Standard Reference Material (SRM) 2670a, 
Toxic Metals in Freeze-Dried Urine (NIST 
2003), was analyzed periodically through-
out the study. We reanalyzed specimens that 
had mercury concentrations of 20 ug/L and 
above. We also randomly selected 2.5% of all 
specimens for a repeat analysis. The limit of 
detection was 0.11 µg/L. Quality control per-
formance for this method has been described 
elsewhere (Minnich et al. 2008).
The analytical performance for the 
ICP-MS urine mercury method has also been 
assessed periodically by external quality assess-
ment schemes (EQAS) operated by the Institut 
national de santé publique du Québec, Le 
centre de toxicology du Québec; the German 
EQAS, University Erlangen-Nuremberg, 
Germany; the United Kingdom National 
EQAS for Trace Elements; and the Programa 
Interlaboratorios de Control de Calidad de 
Metales en Orina (PICC- Met U), Spain, and 
has been found to be satisfactory. In addi-
tion, the Wadsworth Center’s Laboratory of 
Inorganic and Nuclear Chemistry organizes 
and participates in the NYS DOH proficiency 
testing scheme for urine mercury.
Mercury concentrations are presented both 
uncorrected (micrograms per liter) and cor-
rected for creatinine (micrograms per gram). 
The National Center for Environmental 
Health at the CDC measured creatinine 
concentrations using the Roche Creatinine 
Plus Assay and a Roche Hitachi Automatic 
Analyzer, Model 912 (Hitachi, Inc., Tokyo, 
Japan). Creatinine excretion is often used to 
correct for (or normalize) the variable urine 
dilutions in spot urine samples, which are col-
lected at random times throughout the day. 
Urinary creatinine values were unavailable for 
17 of the 1,840 study participants for whom 
urine was collected: 6 specimen results were 
excluded because the measured values were 
≤ 0.3 mg/dL, and 11 were unavailable because 
the urine quantity was insufficient or the sam-
ple was lost or damaged during transport. The 
creatinine assays were performed in 2005 on a 
subset of the urine specimens and completed 
for the remaining specimens in 2009.
Statistical analysis. We applied sample 
weights to all estimates to adjust for differ-
ential selection probabilities and survey non-
response. Weights were poststratified to 
reflect the age, sex, race/ethnicity, and bor-
ough of residence of the NYC population 
(U.S. Census Bureau 2006). We conducted 
statistical analyses using SAS (version 9.1; 
SAS Institute Inc., Cary, NC), and SUDAAN 
10 (Research Triangle Institute, Research 
Triangle Park, NC) to account for the com-
plex sampling design. Mercury levels below 
the limit of detection (0.11 µg/L) were 
assigned a value equal to the limit of detection 
divided by the square root of two.
We calculated crude population-weighted 
geometric means for urine mercury concentra-
tions by taking the antilog of the mean of the 
natural log-transformed values. Upon visual 
inspection, logging the values made a substan-
tial improvement toward the approximation 
of a normal distribution. We used t-tests to 
compare categorical estimates and considered 
a difference to be statistically significant at 
p < 0.05. We used the method of Korn and 
Graubard (1998) to estimate the population-
weighted 95th percentiles and their 95% con-
fidence intervals (CIs).
We fitted multiple linear regressions of the 
natural log-transformed urine mercury con-
centrations on the predictor variables, exclud-
ing persons categorized as Native American 
or Non-Hispanic Other because of insuffi-
cient sample size, and those with missing 
covariate data. We present the exponentiated Inorganic mercury biomonitoring in New York City
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 2 | February 2011  205
model coefficients, which can be interpreted 
as the proportional change in the arithmetic 
mean associated with each level of the pre-
dictor, relative to a referent level, after adjust-
ing for the other predictors in the model. We 
included creatinine concentration in all mod-
els, rather than correcting the urine mercury 
concentrations directly (Barr et al. 2005). We 
also regressed the log-urine mercury on log-
blood mercury concentrations to measure the 
strength of association between these two bio-
markers of exposure [measurements of total 
mercury in blood have been described else-
where (McKelvey et al. 2007)]; we assessed 
correlations using the Pearson correlation coef-
ficient. We considered a result to be statistically 
significant if the 95% CI did not include 1.0.
Follow-up of participants with elevated 
levels of mercury and identification of expo-
sure sources. The study team followed up 
with those participants who had urine mer-
cury levels ≥ 20 µg/L (NYS reportable level; 
NYS DOH 2010) by administering a tele-
phone interview or an in-person interview 
that asked about potential sources of exposure 
(e.g., ritualis  tic and cultural practices, skin 
care products, metallic mercury spills, herbal 
medicine products, fish). When a participant 
reported using a potentially toxic product, we 
collected information on the product, includ-
ing its name, where it was obtained, and how 
it was used. We provided education to all par-
ticipants with elevated mercury levels on the 
potential health effects of mercury and how to 
reduce exposure.
Results
Of the 3,634 selected, eligible survey partici-
pants, 1,999 persons completed the interview 
and at least one component of the examina-
tion, which yielded an overall survey response 
rate of 55%. Measurements of urine mercury 
concentrations were available for 1,840 par-
ticipants (92%), yielding a response rate of 
51% for this analysis. There was no inten-
tional oversampling of particular demographic 
subgroups; we used poststratification survey 
weighting to ensure that the age, sex, race/
ethnicity, and the distributuion of the partici-
pants residing in the study boroughs were the 
same as those of the general NYC population 
(U.S. Census Bureau 2006).
The geometric mean urine mercury con-
centration among NYC adults was 0.73 µg/L 
(95% CI, 0.69–0.79), which is similar to 
the creatinine-corrected mean of 0.69 µg/g 
(95% CI, 0.65–0.73) (Tables 1 and 2). A total 
of 156 samples (9%) were below the limit of 
detection (assigned a value of 0.078 µg/L for 
subsequent analyses); for the remaining 1,684 
samples, the mean urine mercury concentra-
tions ranged from 0.11 to 95 µg/L.
In Tables 1 and 2, we present uncor-
rected and creatinine-corrected urine mercury 
concentrations stratified by demographic 
characteristics and fish consumption. The 
results of the multiple regression modeling 
in Table 2 estimate the proportionate change 
in mercury levels across categories of a pre-
dictor when holding other model covariates 
constant. Patterns of change are similar to 
those of the geometric mean estimates across 
category levels. Women had higher geomet-
ric means than did men in both uncorrected 
(p = 0.07) and creatinine-corrected analyses 
(p < 0.01), with the corrected analyses show-
ing stronger evidence for a difference. Urine 
mercury levels increased with age until the 
fifth or sixth decade, at which point they 
dropped (Table 2). Fish consumption showed 
the strongest association with urine mercury 
levels, based on the proportionate increase 
in urine mercury concentration among those 
who consumed fish or shellfish ≥ 20 times in 
the past 30 days, compared with those who 
never ate fish or shellfish (Table 2). Urine 
mercury levels across all categories of fish con-
sumption were statistically significantly dif-
ferent (p < 0.05) in both uncorrected and 
creatinine-  corrected analyses for all two-way 
comparisons except for the comparisons 
between the two highest categories.
Thirteen individuals (all women) had 
urine mercury concentrations that equaled 
or exceeded the NYS reportable level of 
20 µg/L (weighted NYC population esti-
mate = 26,690). All of the study participants 
with elevated levels were either Hispanic 
(n = 11) or black (n = 2) between the ages of 
21 and 51 years, and all but one black woman 
were born outside the United States. Of the 
11 Hispanic women, 10 were born in the 
Dominican Republic; 4 Dominican women 
had mercury levels > 50 µg/L. The 97.5th 
percentile for urine mercury concentration 
overall was 6.13 µg/L (5.25 µg/g creatinine).
During follow-up interviews with study 
participants who had urine mercury levels 
≥ 20 µg/L, we identified mercury-containing 
skin-lightening creams as the primary expo-
sure source in 9 of 13 cases; we were unable to 
identify a source for 4 individuals. We identi-
fied and confiscated Recetas de la Farmacia 
Normal – Crema Blanqueadora during a visit 
to the home of the study participant who 
had the highest mercury level (95 µg/L). This 
Table 1. Urine mercury concentrations, geometric means, and 95th percentiles for NYC adults.
Characteristics na
Population-weighted geometric 
mean urine mercury 
[µg/L (95% CI)]
Population-weighted 95th 
percentile urine mercury 
[µg/L (95% CI)] 
Total 1,840 0.73 (0.69–0.79) 4.35 (3.95–4.73)
Sex
Male 766 0.69 (0.63–0.76) 3.77 (3.50–4.36)
Female 1,074 0.77 (0.71–0.85) 4.76 (4.20–5.76)
Age (years)
20–29 490 0.66 (0.59–0.74) 4.52 (3.71–5.76)
30–39 425 0.80 (0.70–0.92) 4.75 (4.01–5.55)
40–49 404 0.93 (0.82–1.06) 5.05 (4.12–8.32)
50–59 283 0.80 (0.69–0.94) 4.48 (3.72–6.3)
> 60 238 0.56 (0.48–0.64) 2.70 (2.13–3.04)
Race/ethnicityb
White, non-Hispanic 538 0.67 (0.60–0.75) 3.84 (3.50–4.46)
Black, non-Hispanic 398 0.89 (0.78–1.00) 4.40 (3.62–5.31)
Black, Caribbean-born non-Hispanic 97 1.39 (1.14–1.70) 4.46 (3.61–10.52)
Asian, non-Hispanic 235 0.63 (0.51–0.78) 3.90 (3.09–4.42)
Hispanic 638 0.77 (0.69–0.87) 5.05 (4.31–6.95)
Foreign-born Dominican 149 1.04 (0.82–1.33) 21.18 (7.25–51.29)
Puerto Ricanc 178 0.79 (0.67–0.94) 3.52 (2.63–6.36)
Foreign-born Mexican 78 0.33 (0.24–0.46) 1.90 (1.11–2.74)
Family income ($US)
< 20,000 618 0.66 (0.58–0.74) 5.05 (3.88–6.99)
20,000–49,999 579 0.76 (0.69–0.85) 4.20 (3.72–4.88)
50,000–74,999 259 0.70 (0.59–0.83) 3.70 (3.22–4.14)
≥ 75,000 306 0.92 (0.81–1.05) 4.72 (3.5–6.15)
Education
< High school diploma 527 0.64 (0.56–0.73) 3.99 (3.37–5.11)
≥ High school diploma 1,305 0.77 (0.71–0.83) 4.40 (4.02–4.76)
Place of birth
Continental United States 817 0.70 (0.65–0.76) 3.89 (3.55–4.54)
Outside continental United Statesd 1,017 0.77 (0.69–0.86) 4.42 (4.01–5.35)
Fish or shellfish consumption (number of times in past 30 days)
Never 215 0.50 (0.41–0.61) 3.52 (2.33–6.36)
Up to 9 1,233 0.71 (0.66–0.77) 4.12 (3.72–4.48)
10–19 259 0.92 (0.79–1.07) 5.34 (4.26–9.46)
≥ 20 116 1.02 (0.83–1.25) 3.90 (3.56–5.71)
aNumber of participants does not equal 1,840 because of missing data. bExcludes 27 participants who classified them-
selves as “other.” cPuerto Ricans were not considered foreign born. dIncludes Puerto Rico and U.S. Virgin Islands.McKelvey et al.
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woman had reportedly brought this product 
into NYC from the Dominican Republic. It 
was tested at a commercial laboratory, certi-
fied by the NYS DOH Wadsworth Center 
Environmental Laboratory Accreditation 
Program, and found to contain a mercury 
concentration of 6,190 ppm (0.62% mercury 
by weight).
Because we documented the use of mer-
cury-containing skin-lightening creams by 
Dominicans and other Hispanic racial/ethnic 
groups and by Caribbean-born blacks, we 
looked specifically at urine mercury concen-
trations among participants in these groups 
(Tables 1 and 2). The 97 study participants 
who were categorized as non-Hispanic, 
Caribbean-born black were born in Antigua 
and Barbuda, Bahamas, Barbados, Belize, 
Bermuda, Cuba, Grenada, Haiti, Saint Kitts 
and Nevis, Saint Lucia, Saint Vincent and 
the Grenadines, Trinidad and Tobago, or the 
United States or British Virgin Islands. The 
95th percentile of urine mercury levels among 
Dominicans was highest (21.2 µg/L) com-
pared with all other race/ethnicity groups, 
exceeding the NYS reportable level (20 µg/L). 
Caribbean-born blacks and Dominicans had 
the highest geometric mean urine mercury 
levels in both creatinine-corrected and uncor-
rected analyses (p < 0.01 for each, compared 
with study participants who were neither 
Caribbean-born black nor Dominican).
We observed a statistically significant 
positive association (p < 0.01) between urine 
and blood mercury levels when regressing the 
urine mercury on blood mercury concentra-
tions. Although the correlation was not high 
(Pearson r2 = 31%), we found that partici-
pants with the highest urine mercury levels 
(≥ 10 µg/L) had a geometric mean blood 
mercury concentration of 8.79 µg/L, whereas 
those with urine mercury levels less than 
10 µg/L had a geometric mean of 2.70 µg/L.
Public health actions. Upon discovering 
that illegal mercury-containing skin-lightening 
creams were being used in NYC, DOHMH 
sent out press releases in English and Spanish 
urging people to stop using these products 
immediately and issued an electronic health 
alert to health care providers. The public was 
asked to report the names of any mercury-
containing skin-lightening creams they had 
purchased or used and the stores that were sell-
ing them to the NYC Poison Control Center 
(PCC). The PCC received 139 calls within a 
2-week period in early 2005.
The DOHMH also mailed bilingual press 
releases and consumer warning signs to 270 
non–chain pharmacies, discount and beauty 
supply stores, and botanicas located in neigh-
borhoods with large Dominican populations 
or in ZIP codes where members of the public 
had purchased products (NYC DOHMH 
2005). A team from DOHMH subsequently 
visited these stores and similar stores nearby 
to verify that products with mercury listed 
as an ingredient had been removed from the 
shelves. The Commissioner of Health issued 
orders to embargo or seize remaining prod-
ucts, and store owners were required to pro-
vide the names of distributors and to post 
warning signs in their stores.
Ultimately, 17 different products were 
embargoed or seized from 22 stores and 
subsequently tested for mercury. Of the 12 
products that contained mercury concentra-
tions that exceeded the U.S. Food and Drug 
Administration (FDA) allowable level of 
1 ppm, eight were skin-lightening or beauty 
creams; nine were labeled as manufactured 
in the Dominican Republic, and seven listed 
mercury as an ingredient on the product label 
(Table 3). Four of the 12 products were anti-
septic soaps or creams that were labeled as 
manufactured in the Dominican Republic 
or the European Economic Community. 
Products were sent to the U.S. FDA Region 2 
(Queens, NY) laboratory for analysis. Store 
investigations identified six distributors 
located in New Jersey who had been supplying   
products to NYC stores.
Discussion
NYC conducted the first local HANES in 
the United States under the premise that 
results from national public health surveil-
lance are likely to vary according to regional 
differences in cultural, behavioral, and demo-
graphic composition of the population. Local 
surveillance provides more relevant informa-
tion for targeting resources and outreach and 
offers an opportunity to assess the impact of 
local exposure sources on the population. We 
demon  strated the unique value of local data by 
identifying contaminated skin care products as 
a previously unrecognized source of exposure 
to inorganic mercury in NYC.
Population-based biomonitoring confirmed 
that exposure to inorganic mercury from use of 
mercury-containing skin-lightening creams had 
Table 2. Urine mercury concentrations corrected for creatinine concentrations, geometric means, 














Total 1,823 0.69 (0.65–0.73) 3.75 (3.27–4.36)
Sex
Male 758 0.53 (0.49–0.58) 1.00 (reference) 2.62 (2.20–3.06)
Female 1,065 0.86 (0.80–0.93) 1.44 (1.29–1.62) 4.73 (4.21–5.40)
Age (years)
20–29 486 0.53 (0.47–0.59) 1.00 (reference) 3.54 (2.62–4.79)
30–39 422 0.69 (0.62–0.77) 1.23 (1.06–1.43) 3.24 (2.61–4.27)
40–49 399 0.89 (0.79–1.01) 1.50 (1.30–1.74) 5.25 (3.84–7.40)
50–59 280 0.88 (0.77–1.00) 1.43 (1.21–1.69) 4.52 (3.12–6.32)
> 60 236 0.58 (0.51–0.66) 1.12 (0.94–1.34) 2.97 (2.12–3.26)
Race/ethnicityc
White, non-Hispanic 532 0.72 (0.64–0.80) 1.00 (reference) 3.58 (3.12–4.40)
Black, non-Hispanic 395 0.63 (0.56–0.70) 0.83 (0.71–0.97) 3.01 (2.58–3.67)
Black, Caribbean-born non-Hispanic 97 1.13 (0.95–1.34) 1.45 (1.15–1.82) 4.44 (3.01–6.98)
Asian, non-Hispanic 233 0.77 (0.63–0.93) 0.93 (0.74–1.17) 5.40 (2.72–9.49)
Hispanic 632 0.68 (0.61–0.76) 1.02 (0.87–1.20) 4.33 (3.35–5.69)
Foreign-born Dominican 147 1.00 (0.8–1.25) 1.53 (1.17–2.01) 26.52 (4.87–36.89)
Puerto Ricand 175 0.58 (0.49–0.69) 2.59 (1.64–4.35)
Foreign-born Mexican 78 0.31 (0.24–0.39) 1.82 (0.91–2.48)
Family income ($US)
< 20,000 610 0.63 (0.56–0.70) 1.00 (reference) 4.27 (3.16–5.12)
20,000–49,999 575 0.68 (0.62–0.75) 1.12 (0.98–1.28) 3.26 (2.79–4.51)
50,000–74,999 259 0.66 (0.58–0.74) 1.07 (0.90–1.26) 3.35 (2.40–4.64)
≥ 75,000 301 0.88 (0.77–1.01) 1.39 (1.18–1.62) 4.21 (3.23–5.40)
Education
< High school diploma 521 0.61 (0.54–0.69) 1.00 (reference) 3.35 (2.72–4.87)
≥ High school diploma 1,294 0.72 (0.67–0.77) 1.09 (0.96–1.24) 3.82 (3.26–4.40)
Place of birth
Continental United States 810 0.63 (0.58–0.68) 1.00 (reference) 3.89 (2.95–4.30)
Outside continental United Statese 1,006 0.76 (0.69–0.83) 1.14 (0.98–1.31) 4.30 (3.45–5.00)
Fish or shellfish consumption (number of times in past 30 days)
Never 214 0.44 (0.36–0.54) 1.00 (reference) 3.19 (2.32–5.8)
Up to 9 1,221 0.68 (0.63–0.73) 1.43 (1.16–1.75) 3.41 (3.06–3.83)
10–19 255 0.83 (0.71–0.97) 1.74 (1.32–2.29) 4.38 (3.16–5.64)
≥ 20 116 1.03 (0.85–1.23) 2.23 (1.69–2.94) 4.79 (3.12–5.8)
aThe exponentiated β coefficient from a log-linear multiple regression that includes all covariates in the table; for the 
adjusted analysis, n = 1,715 after excluding participants with missing covariate data. bNumber of participants does not 
equal 1,823 because of missing data. cExcludes 27 participants who classified themselves as “other.” dPuerto Ricans 
were not considered foreign born. eIncludes Puerto Rico and U.S. Virgin Islands.Inorganic mercury biomonitoring in New York City
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occurred in Dominican and possibly Caribbean 
groups in NYC. This exposure source has been 
described in previous investigations of poison-
ings due to use of these products in California, 
Texas, and New Mexico (CDC 1996; Weldon 
et al. 2000). The NYC HANES did not 
query participants about their use of mercury- 
containing products, so we are unable to report 
prevalence of use in NYC. However, in a 1997 
survey of Hispanic communities on the Texas–
Mexico border, 5% of households reported 
at least one person who had used a mercury-
containing skin-lightening cream in the past 
year (Weldon et al. 2000). In contrast to pre-
vious investigations, the relatively low urine 
mercury levels among Mexican New Yorkers 
did not suggest that use of mercury-containing 
creams was common in this group. However, 
the number of Mexicans surveyed was small 
(n = 78).
In the United States, it is illegal to sell 
any skin care product that contains more 
than 1 µg/g (ppm) mercury, with the excep-
tion of eye-area cosmetics or drops, which may 
contain up to 65 µg/g. However mercury- 
containing creams and soaps remain unregu-
lated and available in other countries (IPCS 
1991). In 2003, the U.S. FDA issued import 
alerts on Manning Beauty cream (from 
Mexico), and Dermaline, Miss Key, and Santa 
Crema creams (from the Dominican Republic) 
(U.S. FDA 2003). Three of these products and 
other similar ones were found in NYC stores 
in 2005 (Table 3). The products tested by the 
NYC DOHMH contained mercury concen-
trations up to 41,600 µg/g, or about 4.2% 
by weight (Table 3). We learned from store 
owners that products were being distributed 
by wholesalers in New Jersey, which led the 
New Jersey Department of Health and Senior 
Services to launch an investigation shortly there-
after to embargo products at the wholesale level.
After determining that many products 
seized from NYC shelves were manufactured in 
the Dominican Republic, the NYC DOHMH 
met with the Dominican Consulate. We 
also communicated our findings to the Pan 
American Health Organization. Several 
weeks later, their local office reported to us 
that the Dominican Secretary of Health had 
notified all laboratories to stop manufactur-
ing mercury-containing skin care products. 
Enforcement of the notification will require 
continued political and regulatory support, 
but we believe that studies documenting the 
potentially toxic exposure levels that may 
occur from using contaminated products can 
be used to leverage such support.
We were unable to document exposure to 
inorganic mercury through cultural or ritualis-
tic use of mercury in NYC, among the NYC 
HANES participants with elevated urine 
mercury levels. Few studies describe mercury 
exposure resulting from ritualistic practices, 
but some have suggested that such practices 
may not necessarily result in high or pro-
longed exposures (Riley et al. 2001; Singhvi 
2005). Nonetheless, many jurisdictions, 
including NYS, have passed legislation to 
limit the sale of elemental mercury to reduce 
the potential for exposure and mis  manage-
ment (NYS Department of Environmental 
Conservation 2010).
Overall, our results suggest that expo-
sure to inorganic mercury in NYC adults is 
slightly higher than national levels for men and 
more so for women, based on a comparison 
of NHANES 2003–2004 estimates (Table 4) 
(CDC 2009). Germany is one of the few coun-
tries that has also conducted   population-based 
urine mercury biomonitoring. The creatinine-
corrected geometric mean for NYC adults was 
0.69 (95% CI, 0.65–0.73) compared with 0.34 
(95% CI, 0.33–0.35) µg/g creatinine from the 
1998 German Environmental Surveys (Becker 
et al. 2003). However, the overall NYC geo-
metric mean is not as high as the geometric 
mean among German study participants who 
had mercury amalgams on at least eight teeth 
(0.89 µg/g; 95% CI, 0.82–0.97). In a non-
occupational setting, the presence of mercury 
amalgams in tooth fillings is a strong predictor 
of urine mercury levels (Akesson et al. 1991; 
Kingman et al. 1998). We did not survey for 
the presence of amalgams, so we are unable 
to assess the extent to which mercury amal-
gam fillings influence urine mercury   levels in 
NYC adults.
However, we were able to corroborate 
higher urine mercury levels in individuals 
who consumed fish most frequently, similar 
to other studies (Apostoli et al. 2002; Levy 
et al. 2004). These observations challenge the 
currently held notion that methylmercury in 
fish is not likely to impact mercury exposure 
or accumulation in the kidney (Clarkson and 
Magos 2006). Virtually all mercury present 
in urine is of the inorganic form, whereas 
mercury in fish is predominantly methylated 
(ATSDR 1999; Carrier et al. 2001; IPCS 
1976). One explanation for the observed asso-
ciation between fish consumption and urine 
mercury levels is demethylation of methyl-
mercury in vivo, with subsequent elimination 
Table 3. Results of mercury testing for products obtained from nonchain pharmacies, health and beauty supply stores, discount stores, and botanicas in NYC, 2005.
Product name Place of manufacture Active ingredient listed
Mercury 
content (µg/g)
Type of store(s)  
selling product
Skin-lightening creams
Recetas de la Farmacia Normal–Crema Blanqueadora Dominican Republic Ammoniated mercury 6,190–41,600 Brought into country by 
study participant/Botanica
Dermaline Skin Cream Dominican Republic Amide chloride of mercury 21,100 Beauty supply
Magia Blanca de Michelle Marie Crema Blanqueadora Unknown No mercury listed 18,500 Pharmacy
Dermaline Skin Whitening Cream Dominican Republic No mercury listed 13,600 Beauty supply
Miss Key Crema Blanqueadora Dominican Republic Amide chloride of mercury 9,100 Pharmacy/beauty supply
Crema Santa Dominican Republic Mercury oxide 6,200 Pharmacy/discount/beauty supply
Deluxe Nadinola Bleaching Cream Jamaica 3% Ammoniated mercury 3.47 Beauty supply
Dermaline Beauty Cream Dominican Republic No mercury listed 3.37 Pharmacy
Germicidal soaps/creams/balms
Germicida 200 (soap) European Economic Community No mercury listed 4,770 Botanica
Crema Santa Germicida Dominican Republic No mercury listed 4,700 Pharmacy
Pomada Salva-Vida (balm) Dominican Republic Percl. mercurio: 10% 438 Botanica
Jabon Germicida Contifarma (soap) Dominican Republic 1% Mercury iodine 204 Pharmacy/beauty supply
Table 4. Geometric means and 95th percentiles for adults ≥ 20 years of age who resided in NYC compared 
with the United States, NYC HANES 2004 and NHANES 2003–2004.
Survey n
Crude-weighted geometric mean 
urine mercury [µg/L (95% CI)]
Crude-weighted 95th percentile 
urine mercury [µg/L (95% CI)]
NYC HANES 2004
Total 1,840 0.74 (0.69–0.79) 4.35 (3.95–4.73)
Males 766 0.69 (0.63–0.76) 3.77 (3.50–4.36)
Females 1,074 0.77 (0.71–0.85) 4.76 (4.20–5.76)
NHANES 2003–2004a
Total 1,529 0.50 (0.44–0.56) 3.33 (2.76–3.88)
Data from CDC (2009).McKelvey et al.
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via the kidneys (IPCS 1990). The fish and 
urine mercury association may also explain 
part of the blood and urine mercury asso-
ciation we observed, as fish consumption is 
also positively associated with blood mercury 
  levels (McKelvey et al. 2007).
The NYC HANES conducted in 2004 
opted to conduct both blood and urine mer-
cury biomonitoring. This choice was fortunate, 
as blood mercury biomonitoring alone might 
not have led to the discovery of skin-lightening 
creams as an exposure source. Blood mercury 
levels reported from the NYC HANES iden-
tified fish consumption as a major source of 
exposure. Hispanics had relatively low levels 
of fish consumption and therefore were not 
identified as a subgroup with higher risk of 
exposure to mercury (McKelvey et al. 2007). 
An alternative to biomonitoring for mercury 
exposure in both urine and blood, for the pur-
pose of identifying different exposure sources, 
would be to use a speciation method that dis-
tinguishes between methylmercury and inor-
ganic mercury in blood.
Interpretation of our findings has some 
limitations. Although the NYC HANES sam-
ple selection was designed to be representative 
of the NYC adult population, we cannot rule 
out the presence of bias in our population 
estimates, because the overall response rate 
was 51%. However, we have attempted to 
correct for differences between responders and 
nonresponders using sample weights that take 
into account census block (or block group) 
characteristics such as education, income, for-
eign language spoken at home, racial/ethnic 
composition, household size, and home own-
ership. Weights were further poststratified 
and calibrated so that all NYC HANES esti-
mates are consistent with the cross-tabulated 
age, race/ethnicity, sex, and the population 
sizes of the borough of residence, as estimated 
by the U.S. Census Bureau (2006). We also 
noted that the national HANES interview 
and examination response rate for a popula-
tion of similar age in the NYC area in 2004 
was only slightly higher [58% (Porter K, 
NHANES program, personal communica-
tion)] than the 55% response rate in the NYC 
HANES. Response rates for the urine col-
lection component of the examination were 
slightly lower in both the U.S. and NYC sur-
veys. Nonetheless, it remains possible that 
we did not achieve representativeness within 
the subgroups considered for our weighting 
scheme, which could produce inaccuracy in 
our population estimates.
Laboratory methods for measuring chemi-
cal exposures have become increasingly sensi-
tive, so detecting low levels of mercury in 
the urine of an adult does not necessarily 
imply a health risk. Cohort studies of chil-
dren who have urine mercury levels similar to 
the geometric means we report here have not 
revealed adverse renal or neuro  psychological 
effects (Bellinger et al. 2006; DeRouen et al. 
2006). However, some occupational stud-
ies have documented harmful effects to the 
kidneys and nervous system of workers who 
have urine mercury levels in the range of 
20–50 µg/g creatinine (IPCS 1991). NYC 
HANES results suggest that almost 27,000 
New Yorkers (estimate based on the subset 
of 13 women with such levels) are at risk of 
exposure at this level.
Conclusion
Population-based biomonitoring proved to 
be a valuable tool for identifying a previously 
unrecognized source of exposure to mer-
cury in NYC. The NYC Health Department 
responded to this finding by embargoing 
illegal products and notifying store owners 
and the public that mercury-containing skin- 
lightening creams and other skin care prod-
ucts are dangerous and illegal. Although expo-
sure to inorganic mercury is not a widespread 
problem in NYC, a number of New Yorkers 
who use these products may be at risk of 
adverse health effects.
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